The timelines for developing vaccines against infectious diseases are lengthy, and often
vaccines that reach the stage of large phase 3 field trials fail to provide the desired level of …

Background Although recent epidemiological data suggest that pneumococci may contribute
to the risk of SARS-CoV-2 disease, cases of coinfection with Streptococcus pneumoniae in …

AZD7442 (tixagevimab [AZD8895]/cilgavimab [AZD1061]) is a monoclonal antibody (mAb)
combination in development for the prevention and treatment of coronavirus disease 2019 …

Background Streptococcus pneumoniae interacts with numerous viral respiratory pathogens
in the upper airway. It is unclear whether similar interactions occur with severe acute …

Background Streptococcus pneumoniae interacts with numerous viral respiratory pathogens
in the upper airway. It is unclear whether similar interactions occur with SARS-CoV-2 …

Streptococcus pneumoniae colonization in the upper respiratory tract is linked to
pneumococcal disease development, predominantly affecting young children and older …

In humans, nasopharyngeal carriage of Streptococcus pneumoniae is common and
although primarily asymptomatic, is a pre-requisite for pneumonia and invasive …

Monitoring the presence of commensal and pathogenic respiratory microorganisms is of
critical global importance. However, community-based surveillance is difficult because …

Background The upper respiratory tract is continuously exposed to microorganisms and
noxious elements, leading to local immune responses and the secretion of immune markers …

Background Three billion people in low-and middle-income countries are exposed to
household air pollution as they use biomass fuel for cooking. We investigated the …